|Global Edition

S&P 500 7,241 +1.47%NASDAQ 25,138 +1.88%BTC $78,491 +2.67%ETH $2,307 +1.92%SOL $84.03 +1.13%EUR/USD 1.1729 +0.38%GOLD 4,635 +0.43%S&P 500 7,241 +1.47%NASDAQ 25,138 +1.88%BTC $78,491 +2.67%ETH $2,307 +1.92%SOL $84.03 +1.13%EUR/USD 1.1729 +0.38%GOLD 4,635 +0.43%

GlobalMarkets

Today

Finance

Freedom Broker upgrades Biogen stock rating on Apellis acquisition

Investing.com

May 1, 2026·1 min read

Finance

Freedom Broker upgrades Biogen stock rating on Apellis acquisition

Original article

Freedom Broker upgrades Biogen stock rating on Apellis acquisition

Published by Investing.com

Read full article